| The neutralizing antibody, LY-CoV555, protects against SARS-CoV-2 infection in nonhuman primates BE Jones, PL Brown-Augsburger, KS Corbett, K Westendorf, J Davies, ... Science translational medicine 13 (593), eabf1906, 2021 | 392 | 2021 |
| LY-CoV1404 (bebtelovimab) potently neutralizes SARS-CoV-2 variants K Westendorf, S Žentelis, L Wang, D Foster, P Vaillancourt, M Wiggin, ... Cell reports 39 (7), 2022 | 344 | 2022 |
| Lassa fever in post-conflict Sierra Leone JG Shaffer, DS Grant, JS Schieffelin, ML Boisen, A Goba, JN Hartnett, ... PLoS neglected tropical diseases 8 (3), e2748, 2014 | 246 | 2014 |
| Establishment of an African green monkey model for COVID-19 and protection against re-infection C Woolsey, V Borisevich, AN Prasad, KN Agans, DJ Deer, NS Dobias, ... Nature immunology 22 (1), 86-98, 2021 | 236 | 2021 |
| Most neutralizing human monoclonal antibodies target novel epitopes requiring both Lassa virus glycoprotein subunits JE Robinson, KM Hastie, RW Cross, RE Yenni, DH Elliott, JA Rouelle, ... Nature communications 7 (1), 11544, 2016 | 177 | 2016 |
| Pathogenic Differences between Nipah Virus Bangladesh and Malaysia Strains in Primates: Implications for Antibody Therapy CCBTWG Chad E. Mire, Benjamin A. Satterfield, Joan B. Geisbert, Krystle N ... Scientific Reports 6, 2016 | 151 | 2016 |
| Genetic diversity and histo-blood group antigen interactions of rhesus enteric caliciviruses T Farkas, RW Cross, E Hargitt III, NW Lerche, AL Morrow, K Sestak Journal of virology 84 (17), 8617-8625, 2010 | 148 | 2010 |
| Human-monoclonal-antibody therapy protects nonhuman primates against advanced Lassa fever Nature Medicine, 2017 | 128 | 2017 |
| Post-exposure treatments for Ebola and Marburg virus infections RW Cross, CE Mire, H Feldmann, TW Geisbert Nature Reviews Drug Discovery, 2018 | 119 | 2018 |
| The immunomodulating V and W proteins of Nipah virus determine disease course BA Satterfield, RW Cross, KA Fenton, KN Agans, CF Basler, TW Geisbert, ... Nature communications 6 (1), 7483, 2015 | 99 | 2015 |
| The Domestic Ferret (Mustela putorius furo) as a Lethal Infection Model for 3 Species of Ebolavirus RW Cross, CE Mire, V Borisevich, JB Geisbert, KA Fenton, TW Geisbert The Journal of infectious diseases 214 (4), 565-569, 2016 | 92 | 2016 |
| A two-antibody pan-ebolavirus cocktail confers broad therapeutic protection in ferrets and nonhuman primates ZA Bornholdt, AS Herbert, CE Mire, S He, RW Cross, AZ Wec, ... Cell host & microbe 25 (1), 49-58. e5, 2019 | 90 | 2019 |
| Single injection recombinant vesicular stomatitis virus vaccines protect ferrets against lethal Nipah virus disease CE Mire, KM Versteeg, RW Cross, KN Agans, KA Fenton, MA Whitt, ... Virology journal 10, 1-13, 2013 | 88 | 2013 |
| Analysis of a therapeutic antibody cocktail reveals determinants for cooperative and broad ebolavirus neutralization P Gilchuk, CD Murin, JC Milligan, RW Cross, CE Mire, PA Ilinykh, ... Immunity 52 (2), 388-403. e12, 2020 | 78 | 2020 |
| Treatment of Lassa virus infection in outbred guinea pigs with first-in-class human monoclonal antibodies RW Cross, CE Mire, LM Branco, JB Geisbert, MM Rowland, ML Heinrich, ... Antiviral Research, 2016 | 77 | 2016 |
| Intranasal exposure of African green monkeys to SARS-CoV-2 results in acute phase pneumonia with shedding and lung injury still present in the early convalescence phase RW Cross, KN Agans, AN Prasad, V Borisevich, C Woolsey, DJ Deer, ... Virology journal 17, 1-12, 2020 | 65 | 2020 |
| Quadrivalent VesiculoVax vaccine protects nonhuman primates from viral-induced hemorrhagic fever and death RW Cross, R Xu, D Matassov, S Hamm, TE Latham, CS Gerardi, ... The Journal of Clinical Investigation 130 (1), 539-551, 2020 | 57 | 2020 |
| Vesicular Stomatitis Virus-Based Vaccine Protects Mice against Crimean-Congo Hemorrhagic Fever TW Rodriguez, Sergio E., Cross, Robert W., Fenton, Karla A. Bente, Denis A ... Scientific Reports 9, 2019 | 54 | 2019 |
| Modeling the Disease Course of Zaire ebolavirus Infection in the Outbred Guinea Pig RW Cross, KA Fenton, JB Geisbert, CE Mire, TW Geisbert The Journal of infectious diseases 212 (suppl_2), S305-S315, 2015 | 53 | 2015 |
| Field validation of recombinant antigen immunoassays for diagnosis of Lassa fever ML Boisen, JN Hartnett, JG Shaffer, A Goba, M Momoh, JD Sandi, ... Scientific reports 8 (1), 5939, 2018 | 51 | 2018 |
Christopher C BroderUniformed Services University, Department of DefenseBestätigte E-Mail-Adresse bei usuhs.edu
